Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
4
pubmed:dateCreated
2002-10-2
pubmed:abstractText
Primary sclerosing cholangitis (PSC) predisposes individuals to cholangiocarcinoma; however, the molecular mechanisms involved in the carcinogenesis process remain unclear. Because p16(INK4a) inactivation has been implicated in cholangiocarcinoma, our aims were to examine PSC cholangiocytes for p16(INK4a) gene mutations.
pubmed:grant
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
AIM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
Oct
pubmed:issn
0016-5085
pubmed:author
pubmed:issnType
Print
pubmed:volume
123
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
1090-8
pubmed:dateRevised
2008-11-21
pubmed:meshHeading
pubmed-meshheading:12360471-Bile Duct Neoplasms, pubmed-meshheading:12360471-Bile Ducts, Intrahepatic, pubmed-meshheading:12360471-Cholangiocarcinoma, pubmed-meshheading:12360471-Cholangitis, Sclerosing, pubmed-meshheading:12360471-CpG Islands, pubmed-meshheading:12360471-Cyclin-Dependent Kinase Inhibitor p16, pubmed-meshheading:12360471-DNA Methylation, pubmed-meshheading:12360471-Exons, pubmed-meshheading:12360471-Gene Expression, pubmed-meshheading:12360471-Genes, Reporter, pubmed-meshheading:12360471-Genetic Predisposition to Disease, pubmed-meshheading:12360471-Humans, pubmed-meshheading:12360471-Luciferases, pubmed-meshheading:12360471-Mutagenesis, Site-Directed, pubmed-meshheading:12360471-Mutation, pubmed-meshheading:12360471-Prevalence, pubmed-meshheading:12360471-Promoter Regions, Genetic, pubmed-meshheading:12360471-Transcriptional Activation
pubmed:year
2002
pubmed:articleTitle
p16INK4a promoter mutations are frequent in primary sclerosing cholangitis (PSC) and PSC-associated cholangiocarcinoma.
pubmed:affiliation
Division of Gastroenterology and Hepatology, Mayo Medical School, Clinic, and Foundation, Rochester, Minnesota 55905, USA.
pubmed:publicationType
Journal Article, Research Support, U.S. Gov't, P.H.S., Research Support, Non-U.S. Gov't